filmov
tv
Tumor Biology and CRS/HIPEC Patients - UMass PMP/Appendiceal Cancer Symposium 2012
Показать описание
James Pingpank, Jr. MD discusses the Impact of Tumor Biology on Outcomes of Patients Undergoing CRS and HIPEC for Peritoneal Malignancies at the UMass PMP/Appendiceal Cancer Symposium - Worcester, MA - September 12, 2012
Attendees at this second annual event learned about pseudomyxoma peritonei and non-carcinoid appendiceal tumors and heard from a variety of experts about the prevalence, the signs and symptoms, treatment options, and latest research. Topics presented included surgical and medical oncology perspectives, imaging for appendiceal cancer, insurance coverage, nutrition, exercise and wellness, and patient and family perspectives.
Attendees at this second annual event learned about pseudomyxoma peritonei and non-carcinoid appendiceal tumors and heard from a variety of experts about the prevalence, the signs and symptoms, treatment options, and latest research. Topics presented included surgical and medical oncology perspectives, imaging for appendiceal cancer, insurance coverage, nutrition, exercise and wellness, and patient and family perspectives.
Tumor Biology and CRS/HIPEC Patients - UMass PMP/Appendiceal Cancer Symposium 2012
CRS & HIPEC
Hyperthermic intraperitoneal chemotherapy (HIPEC) surgery for ovarian cancer patient
Overview of HIPEC for Nurses and APPs | Ian Solsky, MD, MPH
Types of Cancer Treated with HIPEC | Surgeon Q&A with Dr. Jonathan Greer | HipecTreatment.com
HIPEC surgery for cancer | Ohio State Medical Center
Management of appendiceal cancers: From pathology to treatment
Expanding the Toolkit to Fight Ovarian Cancer: HIPEC, Targeted Therapy and Beyond
Are Minimally Invasive Techniques Fit for HIPEC? | Minimally Invasive GI Surgery #hipec #cancer #GI
HIPEC Q&A with Goshen Center for Cancer Care's Dr. Leonard Henry | HipecTreatment.com
HIPEC Q&A with Surgical Oncologists from Johns Hopkins Kimmel Cancer Center | HipecTreatment.com
ModPath Chat Ep 49 - Heterogeneity of molecular alterations in CRC w peritoneal carcinomatosis
Locoregional Therapy for Peritoneal Carcinomatoisis: To be Aggressive or not to be?
Update 1: Regional/IP Therapies for Low-volume Appendiceal Carcinomas and Pseudomyxoma Peritonei
HIPEC In Ovarian Cancer: The Need For OVHIPEC 2
What types of cancer can be treated with HIPEC? -Dr. Somashekhar S P
Factors deciding if HIPEC should be performed | Dr Vinay Samuel Gaikwad
HIPEC Animation
OVHIPEC 1 Trial results- Prof Henk Schreuder
ModPath Chat Episode 49: Heterogeneity of molecular alterations in CRC w/ peritoneal carcinomatosis
3 Surgeons Answer 'Can HIPEC Cure Cancer?' | HIPEC Q&A with UM Sylvester | HipecTrea...
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer- Dr. Abhinav Deshpande
VF HIPEC / PIPEC Masterclass Q & A session
Colorectal Peritoneal Metastases (CPM): Key facts
Комментарии